We used established gene markers to confirm that most of the tumor infiltrating lymphocytes, such as activated CD8+ T cells, dendritic cells (DCs), CD56+ natural killer cells, macrophages, and natural killer T cells, exhibited significantly higher levels in Cluster 3 and lower levels in Cluster 1 (Figure 3F). The gene discussed is NCAM1; the disease is neoplasm.